Board of Directors

Dr. Kozarich joins ActivX with over 20 years experience in academic and pharmaceutical research. Most recently, he was Vice President at Merck Research Laboratories, where he was responsible for programs including antimicrobial drug discovery, enzymology, 5a-reductase biology, lipid biochemistry, nuclear receptors, ion channels and structural biology. He has been involved in a number of Merck drug programs, including Propecia, Type-1 5a-reductase inhibitor, and MRSA carbapenams. He also has had primary responsibility for a number of Merck collaborations with biotechnology companies, such as Aurora Biosciences, Cubist and KaroBio. In addition, he has played a major role in Merck's acquisition of SIBIA and in the development of its new Boston Research Center. Previously, Dr. Kozarich held faculty positions at the University of Maryland, College Park, and Yale University School of Medicine. He also served as Vice President, Research and Development at Alkermes, a biotechnology company that develops products based on sophisticated drug delivery technologies. Dr. Kozarich is internationally known for his work on enzyme mechanisms and on the chemistry of DNA cleaving antitumor drugs. He was an American Cancer Society Faculty Research Awardee and in 1988 received the Pfizer Award in Enzyme Chemistry of the American Chemical Society for his unique and broad research contributions. He has also served on numerous government and academic committees. Dr. Kozarich has authored over 125 primary scientific publications and holds three patents.

President, Corporate Officer, Executive Director, Research & Development Headquarters of Kyorin Pharmaceutical Co., Ltd.

Dr. Hirai joined Kyorin in 1972. His previous positions at Kyorin included Senior Director of Discovery Research Headquarters, Director of the R & D Management Department, Director of R & D, Strategy and Business Development and Director of the Pharmaceutical Strategy Department. Dr. Hirai received Ph. D. from Gunma University, School of Medicine and he graduated from Yamanashi University, Faculty of Engineering.

Corporate Officer, Executive Director, Head of Exploratory & Development Research Center of Kyorin Pharmaceutical Co., Ltd.

Dr. Komuro Joined Kyorin in 1976. He has been the Head of Development Research Laboratories since 2005 until present. Dr. Komuro received Ph.D. from the University of Tokyo, School of Pharmacy, and he graduated from Ibaraki University, School of engineering.

Director of Business Development, Kyorin Co., Ltd. & Kyorin Pharmaceutical Co., Ltd.

Mr. Takahashi joined Kyorin in 1984. He was the Vice President of Kyorin USA, Inc. (Teaneck, New Jersey) during 2001-2003. He has been the Director of Business Development since 2005 until present. Mr. Takahashi graduated from Saitama University, Faculty of Liberal Arts (Humanity & Social Science).

Mr. Yoh Ito, Vice President and Chief Financial Officer of ActivX, is also the Director of Finance & Accounting of Kyorin Pharmaceutical Co. Ltd. He joined Kyorin in 2003 and previously held the position of Senior Manager of Strategies & Business Development Headquarters. Prior to Kyorin, Mr. Ito was Managing Director of Capital Arts, Inc. He received his MBA from Cornell University and graduated from the University of Tokyo.